Abbott Labs, Amgen and Abbott Labs Among BlackRock Investment’s Largest Healthcare Positions

Wall St. Watchdog reveals information regarding BlackRock Investment Management LLC’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 346 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $5.758 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, BlackRock Investment Management LLC reported holding 9,857,078 shares with a market value of $655,692,795. This comprised 1.12% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 10,345,889 shares with a market value of $658,929,656. This comprised 1.32% of the total portfolio. The net change in shares for this position over the two quarters is 488,811. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, BlackRock Investment Management LLC reported holding 32,358,349 shares with a market value of $666,582,002. This comprised 1.14% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 32,993,255 shares with a market value of $583,320,758. This comprised 1.17% of the total portfolio. The net change in shares for this position over the two quarters is 634,906. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, BlackRock Investment Management LLC reported holding 12,146,228 shares with a market value of $428,640,397. This comprised 0.73% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 12,632,330 shares with a market value of $413,077,201. This comprised 0.83% of the total portfolio. The net change in shares for this position over the two quarters is 486,102. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, BlackRock Investment Management LLC reported holding 9,843,382 shares with a market value of $285,064,334. This comprised 0.49% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 9,710,063 shares with a market value of $304,701,769. This comprised 0.61% of the total portfolio. The net change in shares for this position over the two quarters is -133,319. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, BlackRock Investment Management LLC reported holding 5,411,637 shares with a market value of $284,760,333. This comprised 0.49% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 5,733,990 shares with a market value of $293,236,245. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is 322,353. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, BlackRock Investment Management LLC reported holding 5,191,265 shares with a market value of $302,910,305. This comprised 0.52% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 5,212,396 shares with a market value of $286,473,279. This comprised 0.57% of the total portfolio. The net change in shares for this position over the two quarters is 21,131. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, BlackRock Investment Management LLC reported holding 5,751,995 shares with a market value of $296,687,913. This comprised 0.51% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 5,444,595 shares with a market value of $251,104,716. This comprised 0.5% of the total portfolio. The net change in shares for this position over the two quarters is -307,400. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, BlackRock Investment Management LLC reported holding 5,546,101 shares with a market value of $208,145,164. This comprised 0.36% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 5,549,543 shares with a market value of $205,166,611. This comprised 0.41% of the total portfolio. The net change in shares for this position over the two quarters is 3,442. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, BlackRock Investment Management LLC reported holding 3,280,884 shares with a market value of $195,835,961. This comprised 0.34% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 3,376,746 shares with a market value of $189,570,518. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is 95,862. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, BlackRock Investment Management LLC reported holding 2,475,598 shares with a market value of $195,002,846. This comprised 0.33% of the total portfolio. On 09/30/2011, BlackRock Investment Management LLC reported holding 2,519,941 shares with a market value of $164,501,745. This comprised 0.33% of the total portfolio. The net change in shares for this position over the two quarters is 44,343. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.

(Note: Data regarding BlackRock Investment Management LLC’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet